Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Applying to Lewis Cancer and Research Pavilion at Saint Joseph's/Candler · Savannah, Georgia
Answer a few short questions to share with the research team.